Glecaprevir/pibrentasvir and sofosbuvir/ velpatasvir/voxilaprevir have been approved by the FDA- update coming soon.

In addition to updates for all relevant sections in response to the new approvals, the following new sections will be released soon:

  • HCV in Children
  • HCV in Pregnancy
  • HCV Resistance Primer

FDA announcements:



Thursday, August 31, 2017